News

Early Physician Follow-Up Cuts Readmissions


 

The study was supported by grants from the American Heart Association, GlaxoSmithKline, Medtronic, and the Agency for Healthcare Research and Quality. Dr. Hernandez reported financial relationships with Johnson & Johnson, Medtronic, Merck, Novartis, and AstraZeneca. Other authors reported a variety of financial support from drug manufacturers, other health care companies, and nonprofit organizations.

Bruce Jancin, reporting from the annual scientific sessions of the ACC in Atlanta, contributed to this article.

Pages

Recommended Reading

Elderly HF Patients Get Same Benefits From CRT
MDedge Cardiology
One-Fifth of ICD, CRT Recipients Are Over 80
MDedge Cardiology
Higher Furosemide Dosing Shows Advantages
MDedge Cardiology
Erythropoietin May Improve HF-Related Anemia
MDedge Cardiology
Trials Need to Include More Hispanics to Unravel Paradox
MDedge Cardiology
Process-of-Care Intervention Improves Outpatient HF Care
MDedge Cardiology
ICDs Don't Save Women With Heart Failure
MDedge Cardiology
Stage of Kidney Disease Affects Heart Failure Risk
MDedge Cardiology
Heart Failure Boosts Risk For New-Onset Diabetes
MDedge Cardiology
Gout Associated With Worse Heart Failure Outcomes
MDedge Cardiology